| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-07 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-06 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |